Biowatch

Launch of 'TrumpRX' Sells Drugs at Steep Discounts: Will Celltrion and Samsung Biologics Face Price Pressure?

Launch of 'TrumpRX' Sells Drugs at Steep Discounts: Will Celltrion and Samsung Biologics Face Price Pressure?

The prescription drug sales platform 'TrumpRX', named after U. S. President Donald Trump, has officially launched.
LigaChemBio Receives Milestone from Czech Sotio Biotech

LigaChemBio Receives Milestone from Czech Sotio Biotech

LigaChem Biosciences announced on the 9th that it will receive milestone payments based on successful product development under the antibody-drug...
High Efficacy and Increased Convenience: The Three Obesity Drugs Awaiting FDA Approval

High Efficacy and Increased Convenience: The Three Obesity Drugs Awaiting FDA Approval

Since the World Health Organization recommended the use of obesity medications for adults last December, the market is...
Eubiologics Reports Net Profit for Two Consecutive Years, What’s Next?

Eubiologics Reports Net Profit for Two Consecutive Years, What’s Next?

Cholera vaccine specialist Eubiologics has shown strong performance growth, recording net profits for two consecutive...
Celltrion

Celltrion "Asthma Drug 'Omrilclo' Captures 60% Market Share in Spain"

Celltrion announced on the 4th that its chronic spontaneous urticaria and allergic asthma treatment, 'Omrilclo ', is...
From 8.7 Billion Deficit to 16.3 Billion Surplus: Seers Strikes Gold in the Middle East

From 8.7 Billion Deficit to 16.3 Billion Surplus: Seers Strikes Gold in the Middle East

"We have been working to penetrate the Middle Eastern market since 2018. The pricing per bed and equipment costs there...
Samsung Bioepis Aflibercept Biosimilar Available for Sale in Europe

Samsung Bioepis Aflibercept Biosimilar Available for Sale in Europe

Samsung Bioepis announced on the 30th that it has signed a patent agreement and licensing contract with the original...
Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?

Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?

American Biogen and Japanese Eisai are moving quickly to change the formulation and dosage of the dementia treatment...
Samsung Bioepis Achieves Record Sales of 1.672 Trillion Won Last Year

Samsung Bioepis Achieves Record Sales of 1.672 Trillion Won Last Year

Samsung Bioepis achieved its highest performance last year in terms of sales. Excluding short-term milestone revenues,...
K-Toxins Heading to China... Will Hugel Be Followed After 5 Years in the Top 3?

K-Toxins Heading to China... Will Hugel Be Followed After 5 Years in the Top 3?

Domestic botulinum toxin companies are racing towards the Chinese market. With Hugel, which entered China first,...